Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Morning or Evening Antihypertensive Drugs on Albuminuria (MORE trial)
TCTR20220722005Phase 2Completed
- Sponsor
- Navamindradhiraj University
- Start
- Mar 2021
- Countries
- 1
01
Overview
Phase 2, randomised trial in hypertension (HTN) (2 arms), sponsored by Navamindradhiraj University. Primary endpoint: Albuminuria. Started Mar 2021; status: completed.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20220722005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220722005.